Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - famciclovir -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - famciclovir -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - famciclovir -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 125 mg - tablet - excipient ingredients: macrogol 8000; hypromellose; titanium dioxide; poloxamer; stearic acid - famciclovir is indicated for:. - the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.. - the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. - suppression of recurrent genital herpes.. - the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir is indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster;. - treatment of recurrent herpes simplex;. - suppression of recurrent herpes simplex.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 250 mg - tablet - excipient ingredients: hypromellose; titanium dioxide; stearic acid; macrogol 8000; poloxamer - famciclovir is indicated for:. - the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.. - the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. - suppression of recurrent genital herpes.. - the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir is indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster;. - treatment of recurrent herpes simplex;. - suppression of recurrent herpes simplex.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 500 mg - tablet - excipient ingredients: macrogol 8000; poloxamer; stearic acid; titanium dioxide; hypromellose - famciclovir is indicated for:,= treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.,= treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,= suppression of recurrent genital herpes.,= treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for:,= treatment of uncomplicated herpes zoster,= treatment of recurrent herpes simplex,= suppression of recurrent herpes simplex.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

apotex nz ltd - famciclovir 125mg - film coated tablet - 125 mg - active: famciclovir 125mg excipient: hypromellose macrogol 8000 poloxamer purified water stearic acid titanium dioxide - apo-famciclovir is indicated for: · the treatment of acute herpes zoster, including ophthalmic zoster and decreases the duration of associated post-herpetic neuralgia (phn). · the acute treatment of first episode and recurrences of genital herpes infections, and for the suppression of recurrent genital herpes. · the treatment of recurrent herpes labialis (cold sores) in immunocompromised adults aged 18 years and over. · in immunocompromised patients with herpes zoster or herpes simplex infections.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

apotex nz ltd - famciclovir 250mg - film coated tablet - 250 mg - active: famciclovir 250mg excipient: hypromellose macrogol 8000 poloxamer purified water stearic acid titanium dioxide - apo-famciclovir is indicated for: · the treatment of acute herpes zoster, including ophthalmic zoster and decreases the duration of associated post-herpetic neuralgia (phn). · the acute treatment of first episode and recurrences of genital herpes infections, and for the suppression of recurrent genital herpes. · the treatment of recurrent herpes labialis (cold sores) in immunocompromised adults aged 18 years and over. · in immunocompromised patients with herpes zoster or herpes simplex infections.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

apotex nz ltd - famciclovir 500mg - film coated tablet - 500 mg - active: famciclovir 500mg excipient: hypromellose macrogol 8000 poloxamer purified water stearic acid titanium dioxide - apo-famciclovir is indicated for: · the treatment of acute herpes zoster, including ophthalmic zoster and decreases the duration of associated post-herpetic neuralgia (phn). · the acute treatment of first episode and recurrences of genital herpes infections, and for the suppression of recurrent genital herpes. · the treatment of recurrent herpes labialis (cold sores) in immunocompromised adults aged 18 years and over. · in immunocompromised patients with herpes zoster or herpes simplex infections.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - famciclovir -